The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Audentes Therapeutics

Related Interviews

Gene Therapy Companies with Better Clinical Data and Benefits Likely to Do Well
October 02, 2018
Yang, Difei

Relatively Healthy Valuations for Development-Stage Companies
October 02, 2018
Nierengarten, David

Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Wal-Mart Stores, Inc.
International Business Machines Corporation
Citigroup Inc.
Bank of America Corporation
Dell Inc.
Exxon Mobil Corporation
Verizon Communications Inc.
AT&T Inc.

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Chief Strategy Officer: Grown Rogue International Inc. (CNSX:GRIN)
Interview with the CFO: CannTrust Holdings Inc. (NYSE:CTST)
Interview with the President and CEO: Red Lion Hotels Corporation (NYSE:RLH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Combining ESG Characteristics with Traditional Financial Analysis
Finding Interesting Opportunities in Enterprise Software
Positioning Investments for a Late-Cycle Economic Environment
ANALYST INTERVIEWS
Data Readouts from CRISPR Trials Will Be Critical in 2019
Being More Selective and Focusing on Data in the Gene Therapy Space
Growing Investor Interest in the Cannabis Sector
Since 1963
© The Wall Street Transcript 1997-2016
Terms and Conditions
Privacy Policy